Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Education Library
  3. ESMO Webinars
  4. ESMO Deep Dive: Lung Cancer - Webinar Series

ESMO Deep Dive: Lung Cancer - Precision Oncology in Lung Cancer - Diagnostics 2025

Aired live on 05 Feb 2025

ESMO-Webinar-Deep-Dive-1000x1000

This content is for ESMO members only.

Login

Learn more about how you can join ESMO

Presentation

Download slides

Programme

  • 5 February 2025
Welcome and introduction
Tom John
Precision through genomics and beyond (multi-omics)
Celine Mascaux
Harnessing liquid biopsy for diagnosis, monitoring
Christian Rolfo
Beyond Xray vision – novel imaging technologies and radiomics
Raquel Lopez
QnA and Discussion
All speakers

Description

This ESMO Deep Dive Lung Cancer Webinar focused on Precision Oncology in Lung Cancer.

Lung cancer remains the leading cause of cancer-related death globally. Advancements in molecular profiling, targeted therapies and novel agents have have significantly improved long-term survival, even in the setting of advanced disease. Many patients, however, struggle with timely diagnosis and molecular profiling, and thus are not able to benefit from precision oncology.

This webinar provides an important update for clinicians on the latest evidence-based recommendations, insights into emerging technologies and practical approaches to precision oncology. This will support better access for patients to precision oncology and optimal care, helping to address current and future challenges of this rapidly evolving therapeutic area.

Learning objectives

  • To acquire a deeper understanding of the clinical course of malignant disease of lung cancer. ​
  • To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for lung cancer.​
  • To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies.​
  • To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects.

Supported by

This ESMO product is supported by unrestricted educational grants.

SB-Boehringer-Ingelheim-Light-Green
SB-Daiichi Sankyo
SB-Gilead
SB-Johnson-and-Johnson
SB-Lilly
SB-Roche

The sponsors have had no control or influence on the content of the webinar.

You may also be interested in...

ESMO Deep Dive: Lung Cancer

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.